Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Sep 29;289(6448):787–788. doi: 10.1136/bmj.289.6448.787

Effect of an oral serotonin antagonist, ketanserin, on plasma ACTH concentrations in Nelson's syndrome.

R W Prescott, W A Ratcliffe, P K Taylor
PMCID: PMC1442912  PMID: 6089950

Abstract

A study was performed to see whether ketanserin, a serotonin antagonist, would reduce the raised concentrations of adrenocorticotrophic hormone (ACTH) in patients with Nelson's syndrome. Six patients who had undergone bilateral adrenalectomy for Cushing's disease and who had Nelson's syndrome were given ketanserin 40 mg twice daily and placebo, for at least two months each, in a double blind crossover study. Ketanserin had no effect on ACTH concentrations. In healthy people serotonin seems to have a stimulatory role in the regulation of ACTH secretion, and the effect of ketanserin in reducing the ACTH response to hypoglycaemia suggested that it might prove useful in Nelson's syndrome. These results show that it is not indicated in these patients.

Full text

PDF
787

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronin N., Krieger D. T. Sustained remission of Nelson's syndrome after stopping cyproheptadine treatment. N Engl J Med. 1980 Feb 21;302(8):453–455. doi: 10.1056/NEJM198002213020808. [DOI] [PubMed] [Google Scholar]
  2. Dornhorst A., Jenkins J. S., Lamberts S. W., Abraham R. R., Wynn V., Beckford U., Gillham B., Jones M. T. The evaluation of sodium valproate in the treatment of Nelson's syndrome. J Clin Endocrinol Metab. 1983 May;56(5):985–991. doi: 10.1210/jcem-56-5-985. [DOI] [PubMed] [Google Scholar]
  3. Lewis D. A., Sherman B. M. Serotonergic stimulation of adrenocorticotropin secretion in man. J Clin Endocrinol Metab. 1984 Mar;58(3):458–462. doi: 10.1210/jcem-58-3-458. [DOI] [PubMed] [Google Scholar]
  4. Lytras N., Grossman A., Perry L., Tomlin S., Wass J. A., Coy D. H., Schally A. V., Rees L. H., Besser G. M. Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary. Clin Endocrinol (Oxf) 1984 Jan;20(1):71–84. doi: 10.1111/j.1365-2265.1984.tb00061.x. [DOI] [PubMed] [Google Scholar]
  5. Prescott R. W., Kendall-Taylor P., Weightman D. R., Watson M. J., Ratcliffe W. A. The effect of ketanserin, a specific serotonin antagonist on the PRL, GH, ACTH and cortisol responses to hypoglycaemia in normal subjects. Clin Endocrinol (Oxf) 1984 Feb;20(2):137–142. doi: 10.1111/j.1365-2265.1984.tb00068.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES